Dr. David Sommerhalder, MD
Claim this profileNEXT Oncology
Area of expertise
Solid Tumors
David Sommerhalder, MD has run 17 trials for Solid Tumors. Some of their research focus areas include:
Cancer
David Sommerhalder, MD has run 8 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
NEXT Oncology
New Experimental Therapeutics Of San Antonio (NEXT Oncology)
Clinical Trials David Sommerhalder, MD is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of Risvutatug rezetecan (Ris-Rez), also known as GSK5764227. The study will also see how the levels of Ris-Rez will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab, tarlatamab, dostarlimab
Recruiting
1 award
Phase 1
2 criteria
TSN1611
for Cancer
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors. This study will consist of a phase 1 dose escalation part and phase 2 dose expansion part. This study will evaluate the efficacy of TSN1611 at RP2D(s) through ORR using RECIST version 1.1, and determine and confirm the MTD/RP2D for TSN1611 in combination with cetuximab, in combination with cetuximab and mFOLFOX6, in combination with gemcitabine and albumin-bound paclitaxel in subjects with selected solid tumors.
Recruiting
1 award
Phase 1 & 2
3 criteria
More about David Sommerhalder, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 27 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments David Sommerhalder, MD has experience with
- Pembrolizumab
- AMV564
- MPT-0118
- Nab-paclitaxel
- ORIC-101
- BBP-398 (Formerly Known As IACS-15509)
Breakdown of trials David Sommerhalder, MD has run
Solid Tumors
Non-Small Cell Lung Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Sommerhalder, MD specialize in?
David Sommerhalder, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is David Sommerhalder, MD currently recruiting for clinical trials?
Yes, David Sommerhalder, MD is currently recruiting for 9 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that David Sommerhalder, MD has studied deeply?
Yes, David Sommerhalder, MD has studied treatments such as Pembrolizumab, AMV564, MPT-0118.
What is the best way to schedule an appointment with David Sommerhalder, MD?
Apply for one of the trials that David Sommerhalder, MD is conducting.
What is the office address of David Sommerhalder, MD?
The office of David Sommerhalder, MD is located at: NEXT Oncology, San Antonio, Texas 78229 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.